Gaël Dos Santos (Gael Dos Santos)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Drug safety

Human vaccines & immunotherapeutics

Open forum infectious diseases

JMIR public health and surveillance

GlaxoSmithKline Biologicals SA

Université Paris-Sud (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Biologicals SA Nov 01 2011

Belgium

Epidemiologist :: Clinical & Epidemiology

Education History

Université Paris-Sud Oct 01 2006 - Dec 16 2009

France

PHD

Publications

Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety 47 (4) (2024)
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety 47 (4) (2024)
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety 47 (4) (2024)
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety (2024)
Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older. Drug safety 47 (4) (2024)
Samantha Fry, Kulkanya Chokephaibulkit, Sridevi Pallem, Ouzama Henry, Yongjia Pu, Agnes Akawung, Joon Hyung Kim, Emad Yanni, Antonella Nadia Tullio, Linda Aurpibul, Christine Mui Fong Lee, Ana Ceballos, Khalequ Zaman, Ivonne Abadía de Regalado, Khatija Ahmed, Diana Andrea Arias Fernandez, Sri Wahyu Taher, Juliana Caccavo, Conrado Milani Coutinho, Ulises D'Andrea Nores, Tirza De León, Emily Christine D'Silva, Mara De Bernardi, Pablo Dieser, Andrea Falaschi, Clara Del Carmen Flores Acosta, Angela Gentile, Ik Hui Teo, Sheena Kotze, Eduardo Lopez Medina, Ruben Luca, Maria Florencia Lucion, Jacinto Blas Iii V Mantaring, Bladimir Marín, Malahleha Moelo, Marisa Márcia Mussi-Pinhata, Jorge Pinto, Thanyawee Puthanakit, Osvaldo Reyes, Maria Fernanda Roa, María Teresa Rodriguez Brieschke, Camilo Enrique Rodriguez, Juan Nicolas Rodriguez Niño, Alexandre Vargas Schwarzbold, Alexandra Sierra Garcia, Lavitha Sivapatham, Ruey Soon, Juan Carlos Tinoco, Jesús Arnulfo Velásquez Penagos, Gaël Dos Santos
Incidence of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic. Open forum infectious diseases 10 (12) (2023)
Gaël Dos Santos, Tamara Eckermann, Xavier Martínez-Gómez, Jose Parra, Ugo Nwoji, Ignacio Salamanca de la Cueva
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring. Influenza and other respiratory viruses 17 (3) (2023)
Daniel Molnar, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, Ruprecht Schmidt-Ott, Martin Eichner, Markus Schwehm, Gaël Dos Santos, Bernhard Ultsch, Rafik Bekkat-Berkani, Alfred von Krempelhuber, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen
Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany. Human vaccines & immunotherapeutics 18 (5) (2022)
Javier Diez-Domingo, Laurence Torcel-Pagnon, Antonio Carmona, Odile Launay, Gaël Dos Santos, Caterina Rizzo, Mendel Haag, Anke Stuurman, Jos Nauta, Alfredo Vannacci, Simon de Lusignan, Elena Del Rey, Miriam Levi, Bruno Lina, Stefania Bellino, Samantha Nye, Pieter Neels, Hanna Nohynek, Cédric Mahé, null null
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative. Expert review of vaccines 21 (12) (2022)
Gaël Dos Santos, Hao Wang, Pooja Jindal, Maria Rybo, Hélène Roul, Sridevi Pallem, Tamara Eckermann, Lode Godderis, Xavier Martínez-Gómez, Eric Godard, Muriel Soler, Mitra Yousefi, Ignacio Salamanca de la Cueva, Ugo Nwoji
Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season. Infectious diseases and therapy 11 (1) (2021)
Gaël Dos Santos, Bach-Yen Nguyen, Silvia Damaso, Lode Godderis, Xavier Martínez-Gómez, Tamara Eckermann, Hugo Loos, Ignacio Salamanca de la Cueva, Vishvesh Shende, Alexander C Schmidt, Anne Yeakey
Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season. Drug safety 43 (3) (2020)
Simon de Lusignan, Silvia Damaso, Filipa Matos Ferreira, Rachel Byford, Christopher McGee, Sameera Rankiri Pathirannehelage, Vishvesh Shende, Ivelina Yonova, Alexander C Schmidt, Anne E Schuind, Gaël Dos Santos
Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season. Human vaccines & immunotherapeutics 16 (8) (2020)
Simon de Lusignan, Ana Correa, Gaël Dos Santos, Nadia Meyer, François Haguinet, Rebecca Webb, Christopher McGee, Rachel Byford, Ivelina Yonova, Sameera Rankiri Pathirannehelage, Filipa Matos Ferreira, Simon Jones
Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study. JMIR public health and surveillance 5 (4) (2019)
Simon de Lusignan, Filipa Matos Ferreira, Silvia Damaso, Rachel Byford, Sameera Rankiri Pathirannehelage, Anne Yeakey, Ivelina Yonova, Anne E Schuind, Gaël Dos Santos
Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting card. Human vaccines & immunotherapeutics 15 (5) (2019)
Gaël Dos Santos
Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives. Human vaccines & immunotherapeutics 15 (11) (2019)
Ruprecht Schmidt-Ott, Daniel Molnar, Anastassia Anastassopoulou, Emad Yanni, Claudia Krumm, Rafik Bekkat-Berkani, Gaël Dos Santos, Philipp Henneke, Markus Knuf, Markus Schwehm, Martin Eichner
Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations. Human vaccines & immunotherapeutics 16 (4) (2019)

Gaël Dos Santos.css-eqlu8i{font-size:small;padding-left:4px;} (Gael Dos Santos)

Publication Activity (10 Years)

Top Topics

Top Venues

Gaël Dos Santos (Gael Dos Santos)